The novel benzimidazole derivativeBRP‐7 inhibits leukotriene biosynthesisin vitroandin vivoby targeting 5‐lipoxygenase‐activating protein (FLAP)
- 27 May 2014
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 171 (12) , 3051-3064
Abstract
Background and Purpose: Leukotrienes (LTs) are inflammatory mediators produced via the 5‐lipoxygenase (5‐LOX) pathway and are linked to diverse disorders, including asthma, allergic rhinitis and cardiovascular diseases. We recently identified the benzimidazole derivativeBRP‐7 as chemotype for anti‐LTagents by virtual screening targeting 5‐LOX‐activating protein (FLAP). Here, we aimed to reveal thein vitroandin vivopharmacology ofBRP‐7 as an inhibitor ofLTbiosynthesis.Experimental Approach: We analysedLTformation and performed mechanistic studies in human neutrophils and monocytes, in human whole blood (HWB) and in cell‐free assays. The effectiveness ofBRP‐7in vivowas evaluated in rat carrageenan‐induced pleurisy and mouse zymosan‐induced peritonitis.Key Results: BRP‐7 potently suppressedLTformation in neutrophils and monocytes and this was accompanied by impaired 5‐LOXco‐localization withFLAP. Neither the cellular viability nor the activity of 5‐LOXin cell‐free assays was affected byBRP‐7, indicating that a functionalFLAPis needed forBRP‐7 to inhibit LTs, andFLAPbound toBRP‐7 linked to a solid matrix. Compared with theFLAPinhibitorMK‐886,BRP‐7 did not significantly inhibitCOX‐1 or microsomal prostaglandinE2synthase‐1, implying the selectivity ofBRP‐7 forFLAP. Finally,BRP‐7 was effective inHWBand impaired inflammationin vivo, in rat pleurisy and mouse peritonitis, along with reducingLTlevels.Conclusions and Implications: BRP‐7 potently suppressesLTbiosynthesis by interacting withFLAPand exhibits anti‐inflammatory effectivenessin vivo, with promising potential for further development.Keywords
This publication has 48 references indexed in Scilit:
- Efficacy, safety and tolerability of GSK2190915, a 5-lipoxygenase activating protein inhibitor, in adults and adolescents with persistent asthma: a randomised dose-ranging studyRespiratory Research, 2013
- The nuclear membrane leukotriene synthetic complex is a signal integrator and transducerMolecular Biology of the Cell, 2012
- Leukotrienes as Modifiers of Preclinical Atherosclerosis?The Scientific World Journal, 2012
- On the inhibition of 5‐lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivoBritish Journal of Pharmacology, 2011
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthmaProceedings of the National Academy of Sciences, 2008
- Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea‐pig modelBritish Journal of Pharmacology, 2008
- Myrtucommulone from Myrtus communis induces apoptosis in cancer cells via the mitochondrial pathway involving caspase-9Apoptosis, 2007
- The molecular mechanism of the inhibition by licofelone of the biosynthesis of 5‐lipoxygenase productsBritish Journal of Pharmacology, 2007